Immuneel Therapeutics funding, investors and company details

Immuneel Therapeutics is an emerging Healthcare startup from Bengaluru, working in the space of Develops and manufactures advanced CAR-T cell therapies for treating blood cancers and solid tumors. Founded by Kiran Mazumdar Shaw.

Company: Immuneel Therapeutics Private Limited
Sector: Healthcare
Location: Bengaluru
Founders: Kiran Mazumdar Shaw
Total funding raised: ₹318.43 Cr

Company overview

Immuneel Therapeutics develops and manufactures advanced CAR-T cell therapies for treating blood cancers and solid tumors, conducting clinical trials like phase II IMAGINE study for B-cell malignancies, and operates cGMP facilities for decentralized production to enable affordable access through hospital partnerships and global technology licensing. It advances cell and gene therapies via process development, quality compliance, regulatory approvals, and delivery models targeting hematologic cancers HIV and genetic diseases.

Funding rounds

Latest round (Series B): ₹100.00 Cr. ($ 10.62 Mn), 2026-06-08. Investors: Eight Roads ventures, Rainmatter (Zerodha), F-Prime Capital
Past round (Series A): ₹100.00 Cr. ($ 11.95 Mn), 2024-07-10. Investors: Taiba Middle East FZ LLC
Past round: $ 15.00 Mn (₹118.43 Cr.), 2022-06-21. Investors: True North LLP, F-Prime Capital